Sol-Gel Technologies (SLGL) Short-term Investments (2018 - 2024)
Sol-Gel Technologies (SLGL) reported Short-term Investments of $12000.0 for Q4 2024, down 99.94% year-over-year from $20.5 million in Q1 2024, and down 99.94% on a QoQ basis from $20.5 million in Q4 2023.
Sol-Gel Technologies (SLGL) has 7 years of Short-term Investments data on file, last reported at $12000.0 in Q4 2024.
- Quarterly Short-term Investments fell 99.94% year-over-year to $12000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $12000.0 (down 99.94% YoY) and the FY2024 annual result came in at $12000.0, down 99.94% from the prior year.
- Short-term Investments declined to $12000.0 in Q4 2024 per SLGL's latest filing, from $20.5 million in the prior quarter.
- Across five years, Short-term Investments topped out at $21.7 million in Q4 2020 and bottomed at $12000.0 in Q4 2024.
- The 5-year median for Short-term Investments is $8.7 million (2022), against an average of $10.5 million.
- The widest annual swing landed in 2022, when Short-term Investments surged 407.78%; it then sank 99.94% in 2024.
- Tracing SLGL's Short-term Investments over 5 years: stood at $21.7 million in 2020, then tumbled by 92.11% to $1.7 million in 2021, then surged by 407.78% to $8.7 million in 2022, then soared by 135.9% to $20.5 million in 2023, then slumped by 99.94% to $12000.0 in 2024.
- Per Business Quant, the three latest SLGL Short-term Investments figures stand at $12000.0 (Q4 2024), $20.5 million (Q4 2023), and $8.7 million (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Sol-Gel Technologies | 205.76 Mn | 194.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12,000.00 |
| Dec 31, 2023 | 20.47 Mn |
| Dec 31, 2022 | 8.68 Mn |
| Dec 31, 2021 | 1.71 Mn |
| Dec 31, 2020 | 21.65 Mn |
| Dec 31, 2019 | 40.97 Mn |
| Dec 31, 2018 | 56.66 Mn |